How should I diagnose and manage a 60-year-old man with known diabetes, acute coronary syndrome (positive troponin I, ST‑segment depression in leads V5‑V6), uncontrolled hyperglycemia, and overt hyperthyroidism (suppressed TSH, elevated free T4) presenting with chest tightness, dyspnea, abdominal pain, and vomiting?

Diagnosis: NSTEMI with Overt Hyperthyroidism and Diabetic Ketoacidosis

This patient requires immediate dual-track management: aggressive ACS treatment with early invasive strategy while simultaneously correcting hyperthyroidism and hyperglycemic crisis, with careful attention to fluid balance given the competing demands of DKA resuscitation and cardiac dysfunction.

Immediate Diagnostic Confirmation

Acute Coronary Syndrome

• NSTEMI confirmed by positive troponin I with ST-segment depression in V5-V6 1
• Calculate GRACE or TIMI risk score immediately for prognostication (GRACE preferred for superior prediction of death/MI) 1
• Serial troponins every 3-6 hours to assess peak and trend 1
• Urgent echocardiography to assess left ventricular function and regional wall motion abnormalities

Metabolic Crisis Assessment

• Check arterial blood gas, serum ketones, and anion gap immediately to rule out diabetic ketoacidosis (DKA), which can be precipitated by ACS 2
• The combination of A1C 11%, uncontrolled glucose, vomiting, and abdominal pain raises high suspicion for DKA
• Screen for DKA criteria: glucose >250 mg/dL, pH <7.3, bicarbonate <18 mEq/L, positive ketones 3

Hyperthyroidism Confirmation

• Overt hyperthyroidism confirmed: TSH 0.019 (suppressed), FT4 2.57 (elevated), FT3 3.56 (normal)
• This thyroid storm or severe hyperthyroidism can directly precipitate ACS through increased myocardial oxygen demand, coronary vasospasm, or demand ischemia 4
• Check thyroid-stimulating immunoglobulin or TSH receptor antibodies to differentiate Graves' disease from other causes

---

Critical Management Algorithm

Phase 1: Immediate Stabilization (First 24 Hours)

Cardiac Management - Standard NSTEMI Protocol 1, 3:

1. Antiplatelet therapy:

   • Aspirin 162-325 mg loading dose
   • Ticagrelor 180 mg or prasugrel 60 mg loading (ticagrelor preferred in diabetes for greater absolute risk reduction) 3

2. Anticoagulation:

   • Enoxaparin 1 mg/kg SC twice daily OR unfractionated heparin infusion
   • Adjust for renal function (check eGFR) 3

3. Beta-blocker:

   • Start immediately - serves dual purpose for ACS and hyperthyroidism
   • Metoprolol 25-50 mg PO every 6 hours (titrate to heart rate 60-80 bpm)
   • Critical for hyperthyroidism: controls tachycardia and peripheral conversion of T4 to T3

4. Statin:

   • High-intensity statin (atorvastatin 80 mg or rosuvastatin 40 mg) 3, 5

5. ACE inhibitor:

   • Start once hemodynamically stable

Hyperthyroidism Management:

1. Methimazole 20-30 mg PO every 6-8 hours (or propylthiouracil 200 mg every 6 hours if methimazole contraindicated)

   • PTU preferred in thyroid storm as it blocks peripheral T4→T3 conversion

2. Iodine solution (Lugol's or saturated potassium iodide) 5 drops PO every 6 hours

   • Must give at least 1 hour AFTER thionamide to prevent iodine incorporation

3. Hydrocortisone 100 mg IV every 8 hours if thyroid storm suspected (prevents adrenal insufficiency and blocks T4→T3 conversion)

Hyperglycemia/DKA Management 3:

1. If DKA confirmed (pH <7.3, ketones positive):

   • Fluid resuscitation: 0.9% saline 1-1.5 L in first hour, then 250-500 mL/hr
   • CAUTION: Risk of pulmonary edema given cardiac dysfunction - monitor closely, consider CVP monitoring
   • Insulin infusion 0.1 units/kg/hr after initial fluid bolus
   • Potassium replacement as needed

2. If hyperglycemia without DKA:

   • Target glucose <200 mg/dL (<11 mmol/L) while avoiding hypoglycemia 3
   • Insulin infusion or subcutaneous regimen
   • Avoid intensive insulin therapy (increased hypoglycemia risk without mortality benefit) 3

---

Phase 2: Invasive Strategy Timing (Within 24-72 Hours)

Early invasive strategy (coronary angiography) is indicated 1, 3:

• Timing: Within 24 hours for high-risk features (ongoing chest pain, hemodynamic instability, elevated troponin, ST-segment changes)
• Do NOT delay for hyperthyroidism or hyperglycemia - these are not contraindications
• Diabetes and hyperthyroidism increase risk but should not alter invasive strategy selection 3

Pre-catheterization considerations:

• Ensure adequate hydration for contrast nephropathy prevention 3
• Continue beta-blocker throughout
• Hold metformin if using contrast (restart after 48 hours if renal function stable)

Revascularization approach:

• PCI of culprit lesion(s) as indicated
• Consider complete revascularization if hemodynamically stable 5
• CABG may be needed for multi-vessel disease (as in the case report 2)

---

Phase 3: Ongoing Monitoring and Adjustment

Cardiac monitoring:

• Continuous telemetry for arrhythmias (hyperthyroidism increases atrial fibrillation risk)
• Daily troponin until peak and downtrend
• Repeat ECG if symptoms recur
• Echocardiography to assess for complications (wall motion abnormalities, reduced EF, mechanical complications)

Thyroid monitoring:

• Free T4 and T3 every 2-3 days initially
• Adjust thionamide dose based on response
• Taper hydrocortisone after 2-3 days if thyroid storm excluded
• Continue beta-blocker until euthyroid

Glycemic monitoring:

• Blood glucose every 1-2 hours during insulin infusion
• Transition to subcutaneous insulin when stable
• Target A1C <7% long-term (less stringent if older age, advanced CVD, multiple comorbidities) 3

---

Critical Pitfalls to Avoid

1. Fluid overload: DKA requires aggressive hydration, but cardiac dysfunction from NSTEMI increases pulmonary edema risk 2. Monitor lung exam, oxygen saturation, and consider diuretics if volume overloaded.

2. Delaying revascularization: Do not postpone catheterization to "stabilize" thyroid or glucose first - early revascularization improves survival 1

3. Hypoglycemia: Intensive insulin therapy increases hypoglycemia without mortality benefit 3. Target glucose <200 mg/dL, not normoglycemia.

4. Iodine timing: Giving iodine before thionamide worsens hyperthyroidism by providing substrate for hormone synthesis. Always give thionamide first.

5. Beta-blocker hesitancy: Despite cardiac concerns, beta-blockers are essential for both ACS and hyperthyroidism. Start low-dose and titrate carefully.

6. Contrast nephropathy: Diabetes and potential volume depletion increase risk. Ensure adequate hydration before angiography 3.

7. Atrial fibrillation: Hyperthyroidism dramatically increases risk. Monitor closely and treat aggressively if occurs.

---

Expected Clinical Course

Based on similar case reports 2, expect:

• Troponin peak within 24-48 hours
• Gradual improvement in thyroid function over 1-2 weeks with treatment
• Glucose control within 24-48 hours if DKA present
• Potential need for ICU-level care initially given multi-system involvement 2
• Possible need for mechanical ventilation if pulmonary edema develops 2
• CABG may be required if multi-vessel disease identified 2

The key to success is simultaneous aggressive management of all three conditions rather than sequential treatment, with careful attention to the competing fluid management demands of DKA versus cardiac dysfunction.